# Acetyl-L-Carnitine in Type 2 Diabetes

> **NCT00984750** · PHASE3 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 229 (actual)

## Conditions studied

- Diabetes Type 2
- Hypertension

## Interventions

- **DRUG:** acetyl-L-carnitine/statin (simvastatin)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00984750
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-12
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984750, "Acetyl-L-Carnitine in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00984750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*